01099 國藥控股
按盘价 
20.050 -0.500 (-2.433%) 盈利能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 资产回报率 (%) | 2.420% | 2.435% | 2.400% | 2.474% | 2.473% |
| 股东资金回报率 (%) | 12.694% | 13.121% | 13.123% | 13.851% | 13.857% |
| 资本运用回报率 (%) | 6.380% | 6.568% | 6.682% | 6.701% | 6.836% |
边际利润分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 毛利率 (%) | 8.132% | 8.591% | 8.454% | 8.835% | 8.825% |
| 未计利息、税项、折旧及摊销前利润率 (%) | 4.235% | 4.501% | 4.464% | 4.634% | 4.497% |
| 税前边际利润率 (%) | 3.271% | 3.362% | 3.263% | 3.418% | 3.236% |
| 纯利率 (%) | 1.518% | 1.544% | 1.489% | 1.575% | 1.470% |
变现能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 流动比率 (X) | 1.395 X | 1.359 X | 1.327 X | 1.312 X | 1.289 X |
| 速动比率 (X) | 1.146 X | 1.100 X | 1.092 X | 1.081 X | 1.050 X |
财务杠杆分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 总负债 / 总资产比率 (%) | 68.618% | 69.825% | 70.289% | 71.100% | 71.492% |
| 总债项 / 总资产比率 (%) | 19.244% | 19.078% | 20.383% | 22.018% | 20.430% |
| 净债项 / 总资产比率 (%) | 2.601% | 3.939% | 7.405% | 5.895% | 5.909% |
| 总债项 / 股东资金比率 (%) | 98.927% | 102.235% | 110.474% | 121.590% | 116.273% |
| 长期债项 / 股东资金比率 (%) | 23.135% | 21.973% | 18.855% | 21.579% | 24.188% |
| 净债项 / 股东资金比率 (%) | 13.372% | 21.109% | 40.136% | 32.557% | 33.628% |
| 净现金 / (债项) ($) | (99.73亿) | (143.69亿) | (248.39亿) | (183.49亿) | (159.47亿) |
| 每股净现金 / (债项) ($) | (3.196) | (4.604) | (7.959) | (5.880) | (5.366) |
| 总债项 / 资本运用比率 (%) | 51.994% | 53.608% | 58.884% | 63.889% | 60.285% |
| 利息盈利率 (X) | 7.600 X | 6.273 X | 5.526 X | 5.555 X | 4.997 X |
营运效率分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 存货周转率日数 (日) | 40.277日 | 40.652日 | 37.719日 | 39.334日 | 36.705日 |
| 应收贸易帐周转率日数 (日) | 108.353日 | 112.759日 | 110.936日 | 107.007日 | 98.145日 |
| 应付贸易帐周转率日数 (日) | 86.794日 | 87.760日 | 84.433日 | 85.156日 | 78.968日 |
| 备注： | 实时报价更新时间为22/11/2024 17:59 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) (千) | RMB 3,703,875 |
| 增长率 | -9.759% |
| 每股盈利/(亏损) | RMB 1.190 |
| 每股账面资产净值 (¥) | RMB 24.207 |